BASF and Dyadic Enter Into Research Agreement
News May 16, 2013
BASF and Dyadic International, Inc. have announced that the two Companies have entered into a non-exclusive worldwide research and license agreement.
Under the terms of the agreement, BASF will be able to use Dyadic’s patented and proprietary C1 platform technology to develop, produce, distribute and sell industrial enzymes in certain fields for a variety of applications.
BASF will fund research and development at Dyadic’s research lab in The Netherlands. In addition to this funding, BASF has agreed to pay Dyadic a $6 million upfront license fee, and certain research and commercial milestone fees, as well as royalties upon commercialization.
“Dyadic’s C1 technology will strengthen BASF’s position in the industrial enzyme industry,” said Dr. Carsten Sieden, Senior Vice President Fine Chemicals and Biocatalysis Research, BASF. “We expect this license agreement with Dyadic to result in promising long-term opportunities.”
Dyadic’s President and Chief Executive Officer, Mark Emalfarb, stated, “Empowering BASF, the world’s leading chemical company, with our C1 technology provides them with access to a commercially-proven industrial enzyme production platform. In using its vast resources to develop, manufacture and sell new products from the C1 platform, BASF will have business opportunities for a variety of markets, including animal and human nutrition. This transaction will have long-lasting effects on the industrial enzyme businesses of both Dyadic and BASF.”
Emalfarb concluded, “Dyadic looks forward to working with BASF and utilizing our C1 technology for the expression of next-generation enzyme products for a range of applications. This collaboration is yet another example of Dyadic’s ability to leverage our technologies in a variety of industries.”
NIFA Biotechnology Grants Put Science at Center of Food Safety PolicyNews
The U.S. Department of Agriculture's National Institute of Food and Agriculture announced support for projects to help bridge the gap between biotechnology innovations and the policies on how to use them.READ MORE
Arsenic Exposure in U.S. Public Drinking Water Declines Following New EPA RegulationsNews
New research found that exposure to arsenic in drinking water was significantly reduced among Americans using public water systems following the Environmental Protection Agency regulation on maximum levels of arsenic. However, there were no improvements in arsenic exposure rates among users of private wells, which are not federally regulated.READ MORE